Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) Invested Capital: 2020-2025

Historic Invested Capital for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $141.8 million.

  • Caribou Biosciences' Invested Capital fell 49.56% to $141.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.8 million, marking a year-over-year decrease of 49.56%. This contributed to the annual value of $253.0 million for FY2024, which is 31.34% down from last year.
  • Caribou Biosciences' Invested Capital amounted to $141.8 million in Q3 2025, which was down 14.62% from $166.1 million recorded in Q2 2025.
  • Caribou Biosciences' 5-year Invested Capital high stood at $404.4 million for Q3 2021, and its period low was -$47.7 million during Q2 2021.
  • Its 3-year average for Invested Capital is $275.2 million, with a median of $278.3 million in 2023.
  • Examining YoY changes over the last 5 years, Caribou Biosciences' Invested Capital showed a top increase of 3,707.18% in 2021 and a maximum decrease of 1,201.26% in 2021.
  • Over the past 5 years, Caribou Biosciences' Invested Capital (Quarterly) stood at $387.8 million in 2021, then decreased by 22.42% to $300.9 million in 2022, then grew by 22.44% to $368.4 million in 2023, then crashed by 31.34% to $253.0 million in 2024, then tumbled by 49.56% to $141.8 million in 2025.
  • Its last three reported values are $141.8 million in Q3 2025, $166.1 million for Q2 2025, and $217.2 million during Q1 2025.